<div id="readability-page-1"><p>Neogen Corporation (NASDAQ:NEOG - Free Report) - Analysts at Zacks Research lowered their Q3 2026 EPS estimates for Neogen in a note issued to investors on Wednesday, December 17th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $0.07 for the quarter, down from their prior estimate of $0.08. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen's Q3 2027 earnings at $0.06 EPS, Q4 2027 earnings at $0.07 EPS, FY2027 earnings at $0.30 EPS and Q1 2028 earnings at $0.09 EPS.</p><p>NEOG has been the topic of several other research reports. Piper Sandler  set a $6.50 price target on shares of Neogen and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, October 16th. CJS Securities raised Neogen from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $10.00 target price on the stock in a report on Wednesday, December 10th. Wall Street Zen upgraded Neogen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, December 13th. Finally, Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of Neogen in a research report on Monday. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one  has assigned  a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and a consensus price target of $8.83.</p><p><b>Get Our Latest Stock Report on Neogen</b></p><h2>Neogen Trading Up 5.4%</h2><p>NASDAQ NEOG opened at $7.47 on Friday. The company has a market capitalization of $1.62 billion, a price-to-earnings ratio of -1.56 and a beta of 1.99. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.58 and a quick ratio of 2.26. Neogen has a 12 month low of $3.87 and a 12 month high of $13.40. The company's fifty day moving average price is $6.20 and its two-hundred day moving average price is $5.65. </p><h2>Hedge Funds Weigh In On Neogen</h2><p>Several institutional investors have recently modified their holdings of the company. Savant Capital LLC bought a new stake in  Neogen in the 2nd quarter valued at about $50,000.  Cresset Asset Management LLC acquired a new stake in shares of  Neogen in the second quarter valued at approximately $53,000.  Evergreen Capital Management LLC bought a new stake in shares of  Neogen during the second quarter valued at approximately $56,000.  Blue Trust Inc. boosted its position in shares of  Neogen by 181.7% during the second quarter. Blue Trust Inc. now owns 11,974 shares of the company's stock worth $57,000 after buying an additional 7,724 shares during the period.  Finally, Osaic Holdings Inc. grew its holdings in  Neogen by 183.5% in the 2nd quarter. Osaic Holdings Inc. now owns 12,663 shares of the company's stock worth $61,000 after buying an additional 8,196 shares in the last quarter. Institutional investors own  96.73% of the company's stock. </p><h2>Neogen Company Profile</h2> (Get Free Report)<p>Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides  genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Neogen</li><li>What Are Growth Stocks and Investing in Them </li><li>Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500</li><li>3 Must-Buy Warren Buffett Stocks for Volatile Times</li><li>Forget the Chips: 4 Industrial Plays for the AI Rebound</li><li>EV Stocks and How to Profit from Them </li><li>MongoDB Could Hit Record Highs—But You’ll Need to Move Fast</li></ul> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TkVPRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TkVPRw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Neogen Right Now?</h2><p>Before you consider Neogen, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list.</p><p>While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

NEOG

<p>Zacks Research has lowered its Q3 2026 EPS estimates for Neogen Corporation from $0.08 to $0.07. The consensus estimate for Neogen's full-year earnings is $0.38 per share. Other analysts have mixed ratings on Neogen, with a consensus price target of $8.83. Neogen's stock is currently trading at $7.47, up 5.4%.</p>

Zacks Research Issues Negative Forecast for Neogen Earnings